SIRP - Tshwj xeeb Monoclonal Antibody hauv Suav teb

Lub npe: SIRP - Tshwj xeeb monoclonal antibody
CEEB TOOM: Cov qog nqaij hlav
Hot Tags: sirp - tshwj xeeb monoclonal antibody, Tuam Tshoj sirp - tshwj xeeb monoclonal antibody tuam ntxhab, cov chaw muag khoom, Hoobkas, Fulvestrant txhaj 250mg hauv 5ml, rhG CSF txhaj 150 g unit, Enoxaparin Sodium API, rhIL 11 txhaj {{6}1}mg {r, Recombinant Human Granulocyte Colony-Stimulating Factor

 

1. Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. Lub Vev Xaib:https://www.jiuyuangene.net/

Raws li ib tug frontrunner nyob rau hauv biopharmaceutical txoj kev loj hlob, Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. Nrog rau kev tsom mus rau kev tshawb fawb thiab kev tsim kho tshiab, lub tuam txhab tshwj xeeb hauv kev kho cov protein, tshwj xeeb tshaj yog nyob rau hauv hematology thiab oncology. Nws cov khoom lag luam tseem ceeb, ib qho kev sib koom ua ke ntawm tib neeg granulocyte colony- txhawb nqa, yog qhov ua pov thawj rau nws cov peev txheej bioengineering siab heev. Kev khiav hauj lwm hauv xeev- ntawm-- cov chaw tsim khoom kos duab uas ua raws li GMP cov qauv thoob ntiaj teb, Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. ua kom cov khoom zoo tshaj plaws thiab sib xws. Lub tuam txhab kev cog lus rau kev nce qib tshuaj biotech ua rau nws yog tus khub tseem ceeb hauv ntiaj teb kev noj qab haus huv ecosystem, muab kev kho mob tseem ceeb rau cov neeg mob thoob ntiaj teb.

 

 

2. Biosion, Inc. (Nanjing)

Biosion yog ib nrab ntawm - qhov chaw kho mob - theem biotech tuam txhab tsom mus rau cov tshuaj tiv thaiv kab mob tshiab. Nws cov khoom vaj khoom tsev tseem ceeb BSI-082 yog tag nrho tib neeg los tiv thaiv-SIRP monoclonal antibody tsim los thaiv CD47-SIRP "tsis txhob noj kuv" teeb liab thiab qhib macrophage- kho phagocytosis. Cov molecule qhia tau hais tias muaj kev tshwj xeeb rau ntau hom SIRP thiab txo hematotoxicity piv nrog CD47-targeting agents. BSI-082 tau nkag mus rau theem I kev sim tshuaj hauv Suav teb, ua kom pom kev nyab xeeb zoo thiab ua haujlwm tiv thaiv qog noj ntshav. Lub tuam txhab qhov ntsuas nruab nrab, tsom mus rau cov kav dej thiab lub ntiaj teb kev txhim kho lub tswv yim ua rau nws yog tus neeg ua si nruab nrab hauv SIRP antibody kev tshawb fawb.

 

3.BioRay Pharmaceutical Co., Ltd.

BioRay yog qhov nruab nrab - loj biopharmaceutical firm nrog lub hom phiaj ntawm oncology thiab immunology. Nws cov hlau lead SIRP antibody BR105 tau txais kev pom zoo los ntawm ob qho tib si NMPA thiab FDA. Cov khoom lag luam xaiv khi SIRP thiab zam kev cuam tshuam ntawm cov ntshav liab, qhia txog kev nyab xeeb zoo hauv kev tshawb fawb txog kev kho mob thiab thaum ntxov. Nws kuj tau txais kev tso cai rau menyuam ntsuag siv tshuaj rau kev mob qog noj ntshav hauv Asmeskas. Lub tuam txhab tswj hwm pab pawg R & D lean thiab kev kho mob tsis tu ncua, tso nws tus kheej ua qhov kev sib tw nruab nrab -cov lag luam loj hauv SIRP teb yam tsis koom nrog cov kws tshuaj loj tshaj plaws.

 

4.ImmuneOncia Biotech Co., Ltd.

ImmuneOncia yog qhov nruab nrab - qhov chaw kho mob loj - theem biotech mob siab rau CD47-SIRP txoj kev kho. Nws cov khoom lag luam tseem ceeb IMM01 yog SIRP -Fc fusion protein uas tau nce mus txog lig- theem kev kho mob. Cov molecule yog tsim los txo qis hematotoxicity thiab muaj zog ua rau macrophage phagocytosis. Lub tuam txhab tseem tsim cov tshuaj tiv thaiv bispecific tsom rau SIRP -txoj kev cuam tshuam rau hematological malignancies. Nrog rau kev tsom mus rau lub raj xa dej thiab kev ua haujlwm kho mob tau zoo, ImmuneOncia sawv cev rau qhov nruab nrab - tus neeg ua si loj nrog qhov zoo meej hauv SIRP -targeted tshuaj.

 

5.Cambrian Biopharma (Suzhou)

Cambrian Biopharma yog qhov nruab nrab - lub tuam txhab tshuaj kho mob tshiab uas koom nrog kev tiv thaiv kab mob -oncology antibody nrhiav pom. Nws tau tsim lub platform tsim rau SIRP monoclonal antibody kev txhim kho nrog kev ua kom zoo dua qub thiab kev xaiv. Nws cov neeg sib tw preclinical zoo thaiv CD47 khi thiab ua kom cov qog cell tshem tawm los ntawm macrophages, nrog kev txhim kho kev nyab xeeb dua li cov tshuaj tiv thaiv CD47. Lub tuam txhab muaj cov kws tshaj lij R & D pab neeg thiab nyiaj txiag ruaj khov, tswj xyuas qhov ntsuas nruab nrab thaum ua tiav kev nce qib hauv IND- ua kom muaj kev tshawb fawb.

 

6.Shanghai Yimai Biopharmaceuticals

Shanghai Yimai yog ib qho chaw nruab nrab -cov tuam txhab biotech loj tsom mus rau tom ntej - cov tshuaj tiv thaiv kab mob tiv thaiv kab mob. Nws muaj ntau yam tshuaj tiv thaiv preclinical -SIRP monoclonal antibodies nrog qhov tshwj xeeb siab thiab qis dua - cov phiaj xwm. Cov neeg sib tw no zam kev hla -reactivity nrog SIRP, txo cov kev mob tshwm sim hauv lub cev thiab qhia tias muaj zog tiv thaiv- qog nqaij hlav hauv cov qauv tsiaj. Lub tuam txhab kev cog lus R&D system thiab cov khoom lag luam meej tso cai rau nws kom tswj tau txoj kev loj hlob zoo yam tsis muaj kev nthuav dav ntau, haum rau lub ntsiab lus ntawm kev sib tw nruab nrab -sized enterprise.

 

7.Antengene Corporation (Beijing)

Antengene yog ib qho nruab nrab -loj ua lag luam-stage biopharma tuam txhab nrog cov tswv yim layout hauv SIRP -txog immuno-oncology. Nws tsim cov tshuaj tiv thaiv tshiab uas ua haujlwm nrog CD47-SIRP axis kom thim rov qab qog lub cev tiv thaiv kab mob. Nws qhov chaw kho mob- cov cuab tam theem qhia tau tias muaj kev nyab xeeb zoo thiab muaj peev xwm hauv kev kho mob ua ke. Lub tuam txhab muaj cov kav dej sib npaug thiab kev ua haujlwm nruab nrab, tsom mus rau kev txhim kho kev kho mob thoob ntiaj teb yam tsis muaj kev lag luam loj, ua rau nws yog ib qho tseem ceeb nruab nrab -cov neeg koom nrog SIRP -targeted therapy.